Vaccination Against Hepatitis A for Hemophilic Patients: Is It Necessary?

Abstract

BackgroundHemophilic patients require long-life intravenous infusion of factor concentrates to treat bleedings. This could increase the risk of transmission of blood-borne infections like hepatitis C.ObjectivesThe current study was aimed at investigating the immunity status against hepatitis A in hemophilic patients in south Khorasan and evaluating the necessity of hepatitis A vaccination for this population.Patients and MethodsA cross-sectional descriptive study was conducted between 2014 and 2015 on all hemophilic patients of south Khorasan province, Iran (n = 108) for anti-HAV total, anti- HCV, HBs-Ag, anti-HIV, and anti-HTLV-I /II. Note that no one had already received a hepatitis A vaccine.ResultsAs our results show, 77.8% of the participants (59% under 20 and 88.4% above 20 years old) were seropositive for anti-HAV total; 20.4% and 2.8% (three patients) of the cases were anti-HCV positive and anti-HTLV-1 positive, respectively, while none of the subjects were HBS-Ag or HIV-Ab positive. Seventeen of the patients (15.75%) showed a co-infection of HAV with HCV, and five HCV-infected patients (22.73%) had no immunity against hepatitis A. There was a significant relationship between age, rural life, and anti-HAV positive state in our patients (P < 0.001). No significant relationship between positive anti-HAV status and sex (P = 0.16), severity of hemophilia (P = 0.23), and infection with HIV, HCV, HTLV-1, and hepatitis B (P > 0.05) was detected.ConclusionsMore than 40% of the hemophilic patients under 20 years of age in the present study had no immunity against hepatitis A, and 23% of hepatitis C patients had not had a hepatitis A co-infection yet. Since hepatitis A can show a fulminant course in hepatitis C patients, vaccination against hepatitis A seems necessary in hemophilic patients in the region.

Hepatitis A in the Eastern Mediterranean Region: a comprehensive review

“…Overall, a higher seroprevalence of HAV was generally reported among individuals residing in rural areas compared to urban areas, likely due to limited access to improved water sources and to sanitation facilities. 23 , 26 , 47 , 52 , 55 , 59 , 60 , 62 , 89 , 90 Four studies reported data on HAV seroprevalence by socioeconomic status; 21 , 23 , 75 , 81 collectively the data shows that individuals or families from low-income households (36.8 to 87.7%) had higher HAV seropositivity compared to individuals from middle- or high-income households (5.9 to 50.7%).…”

Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil

“…Hepatitis A virus is one of the most common etiologies of acute hepatitis worldwide 3 , infecting 212 million people per year, including 55 million symptomatic cases and 35,245 deaths globally 4 . As the number of asymptomatic infections is unknown, this number may be underestimated 5 .…”

The Shift of HAV Infection in to adulthood in Iran: Consideration for HAV Vaccination

“…Different reports from Iran show a range of HAV prevalence from 8% to 99%. The most effective ways to combat hepatitis A are proving safe water supplies, food safety, improved public health and the hepatitis A vaccine [5][6][7][8]. During the past three decades, two major changes have been made.…”